EIKN Eikon Therapeutics, Inc.

Fundamentals / CIK 0001861123 / USD

Eikon Therapeutics, Inc. reported $706.2M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open EIKN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for EIKN.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Research & Development $71.83M $75.46M $70.05M $59.31M $69.19M $56.59M
Total Operating Expenses $90.55M $93.39M $87.34M $74.75M $109.6M $71.38M
Operating Income -$90.55M -$93.39M -$87.34M -$74.75M -$109.6M -$71.38M
EBITDA -$85.55M -$88.29M -$82.12M -$69.25M -$105.4M -$67.59M
Net Income -$86.11M -$88.41M -$82.96M -$71.14M -$105.2M -$68.24M
Basic EPS -$1.59 -$1.63 -$2.46 -$24.24 -$36.94 -$26.91
Diluted EPS -$1.59 -$1.63 -$2.46 -$24.24 -$36.94 -$26.91
Basic Shares Outstanding 54.2M 54.1M 33.7M 2.9M 2.8M 2.8M
Diluted Shares Outstanding 54.2M 54.1M 33.7M 2.9M 2.8M 2.8M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for EIKN.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31
Cash & Cash Equivalents $98.48M $142.6M $161.2M $104.9M
Short-Term Investments $363.2M $388.6M $351.0M $231.1M
Cash & Short-Term Investments $461.7M $531.2M $512.2M $336.0M
Total Current Assets $478.1M $547.0M $529.5M $348.9M
Property, Plant & Equipment, Net $128.6M $133.1M $138.1M $142.9M
Long-Term Investments -- -- $83.83M --
Other Non-Current Assets $463K $539K $556K $4.18M
Total Non-Current Assets $228.1M $232.6M $321.3M $245.8M
Total Assets $706.2M $779.6M $850.8M $594.7M
Accounts Payable $6.12M $6.56M $6.00M $681K
Total Current Liabilities $66.27M $55.30M $45.06M $55.01M
Other Non-Current Liabilities $15.00M $15.00M $10.00M $10.00M
Total Non-Current Liabilities $255.6M $257.8M $255.1M $257.3M
Total Liabilities $321.9M $313.1M $300.2M $312.3M
Total Debt (incl. Leases) $249.5M $252.2M $254.8M $257.3M
Common Stock $5.0K $5.0K $5.0K $0
Retained Earnings -$1.18B -$1.09B -$1.00B -$920.5M
Total Stockholders' Equity $384.3M $466.5M $550.7M -$879.0M
Total Equity $384.3M $466.5M $550.7M -$879.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for EIKN.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$86.11M -$88.41M -$82.96M -$71.14M -$105.2M -$68.24M
Depreciation & Amortization $5.00M $5.10M $5.21M $5.50M $4.20M $3.79M
Stock-Based Compensation $3.75M $4.22M $2.78M $3.99M $7.21M $2.97M
Change in Payables -$383K $497K $5.32M $363K -$2.91M $2.28M
Operating Cash Flow -$69.19M -$64.96M -$89.80M -$59.53M -$32.74M -$54.52M
Capital Expenditure -$419K -$251K -$262K -$2.60M -$21.72M -$22.36M
Free Cash Flow -$69.61M -$65.21M -$90.06M -$62.14M -$54.45M -$76.88M
Purchases of Investments -$49.64M -$79.82M -$307.0M -$68.72M -$68.91M -$252.5M
Investing Cash Flow $24.94M $46.43M -$203.2M $27.68M -$35.88M -$213.9M
Common Stock Issued $157K $25K $277K $261K $529K $21K
Financing Cash Flow $157K $25K $349.3M $211K $519K $350.2M
Net Change in Cash -$44.09M -$18.50M $56.29M -$31.65M -$68.09M $81.86M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for EIKN.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 7.21x 9.89x 11.75x -- -- --
Quick Ratio 6.97x 9.61x 11.37x -- -- --
Debt to Equity 0.65x 0.54x 0.46x -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001861123) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:39 UTC · Open in terminal